|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomised,phase Ⅱ trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines显示文摘 | Talbot DC Moiseyenko V van Belle S | 2002 | Br J Cancer2002，86，： | 1 |
| 2 | Capecitabine plus gemcitabine is an active combination for patients wit metastatic breast cancer reracry to antracyclines and taxanes显示文摘 | Andres R Mayordomo JI Moiseyenko V | 2002 | J Clin Oncol2002，20，12： | 1 |
| 3 | Docetaxel when added to cisplatin-5-fluorouracil improves survival and maintains quality-of-life for a longer period in advanced gastric cancer:final results of a phase Ⅲ trial显示文摘 | V Moiseyenko E Van Cutsem S Tjulandin | 2005 | EJC Supplements2005，3，2： | 1 |
| 4 | KRAS status and efficacy in the first -line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience 显示文摘 | Van Cutsem E Lang I D' haens G Moiseyenko V Zaluski J Fol- precht G | 2008 | J Gin Oncol2008，2620，2： | 1 |
| 5 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group显示文摘 | VAN CUTSEM E MOISEYENKO V M TJULANDIN S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 6 | Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer, a report of the V325 study group显示文摘 | van C E Moiseyenko V M Tjulandin S | 2006 | Journal of Clinical Oncology2006，24，31： | 1 |
| 7 | Docetaxel (D), cisplatin (C), flluorouracil (F) comparaed to cisplatin and flluorouracil for chemotherapy-naive patients with meta-static or locally recurrent, unre- sectable gastric carcinoma(MGC ): interim results of a randomized phase Ⅲ trial(V325) 显示文摘 | Van Cutsem E A jani JA Moiseyenko V | 2003 | Proc Am Soc C lin Oncol2003，22，24： | 1 |
| 8 | Arandomized phase Ⅱ study of XelodaTM(capecitabine) vs paclitaxel in breast cancer patients failing previous anthracycline therapy显示文摘 | O′Reilly SM Moiseyenko V TalbotDC etal | 1998 | ProcAm Soc ClinOncol1998，17，： | 1 |
| 9 | Randomised,phase Ⅱ trial comparing oral capecitabine (Xeloda)with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines 显示文摘 | Talbot DC Moiseyenko V Van Belle S | 2002 | Br J Cancer2002，86，： | 1 |
| 10 | Randomized, open-labelled, phase Ⅱ trial of orai capecitabine (Xeloda) vs a reference arm of intravenous CMF(cyclophosphamide, methotrexate and 5-fluorouracil)as first-line therapy for advanced/metastatic breast cancer显示文摘 | Oshaughnessy JA Blum J Moiseyenko V | 2001 | Ann Oncol2001，12，9： | 1 |
| 11 | Docetaxel,cisplatin,5-fluorouracil compared to cisplatin and 5-fluorouracil for chemothempy--naive patients with metastatic or locally recurrent, unresectable gastric carcinoma: interim results of a randomized phase Ⅲ trial(V325) (abstr) 显示文摘 | Ajani JA Van Cutsem E Moiseyenko V | 2003 | Proc Am Soc Clin Oncol2003，22，： | 1 |
| 12 | Cell technologies in immunotherapy of cancer显示文摘 | Moiseyenko V Imyanitov E Danilova A | 2007 | Adv Exp Med Biol2007，601，： | 1 |
| 13 | Docetaxel( D),cisplatin( C ), fluorouracil (F)compared to cisplatin and fluorouracil for chemotherapy naive patients with metastatic or locally recurrent,unresectable gastric carcinoma(MGC) :interim results ofa randomized phase Ⅲ trial(V325) 显示文摘 | Van Cutsem E Ajani JA Moiseyenko V | 2003 | Proc Am Soc Clin Oncol2003，22，24： | 1 |
| 14 | Phase III study of docetaxel and cisplatinplus fluorouracil compared with cisplatin andfluorouracil as first-line therapy for advancedgastric cancer: a report of the V325 StudyCroup显示文摘 | VAN CUTSEM E MOISEYENKO V M TJULANDIN S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 15 | Docetaxel(D),cisplatin,5-fluorouracil compare to cisplatin(C)and 5-fluorouracil (F) for chemotherapy na ve patients with metastasis(MGC):interim results of a randomized phase III trial(V325)显示文摘 | Ajani JA van Cutsem E Moiseyenko V | 2003 | Proc Am Soc Clin Oncol2003，22，： | 1 |
| 16 | Phase Ⅲ study docetaxel and cisplatin plus fluorourcil compared with eisplatin and fluorourcil therapy for advanced gastric career: a report of the V325 Study Group显示文摘 | Van Cutsem E Moiseyenko V M Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 17 | Randomised,phaseⅡtrail comparing oral capecitabine with metast atic breast cancer pretre-ated with anthracyclines显示文摘 | Talbot DC Moiseyenko V Van BS | 2002 | Br J Cancer2002，86，： | 1 |
| 18 | capecitabine plus Gemcit-abine is an active combination for patients with metastatic breast cancer reracry to anthracyclines and taxanes显示文摘 | Andres R Mayordomo JI Moiseyenko V | 2002 | Jclin Oncol2002，20，12： | 1 |
| 19 | A randomized phase Ⅱ study of Xeloda (capecitabine) vs CMF as first line chemotherapy of breast cancer in women aged≥55 years显示文摘 | O'shaughnessy J Moiseyenko V Bell D | 1998 | Proc Am Soc Clin Oncol1998，17，： | 1 |
| 20 | PhaseⅢstudy of docetaxel and cisplatin plus fluorouracil comparedwith cisplatin and fluorouracil as first-line therapy for ad-vanced gastric cancer:a report of the V325 Study Group显示文摘 | Van Cutsem E Moiseyenko V M Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员